Lipid-sensing GPCRs in Cardiometabolic Diseases: Emerging Roles for GPR84
KOBRA Reports · 15.06.2026 · 2
DOI: 10.64066/kobrareports.26.0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift KOBRA Reports, online erschienen am 15.06.2026. Verfasst von Chang Yeob Han und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Korea Bio Research Association.
Abstract (Originalsprache)
Cardiometabolic diseases are characterized by the integration of metabolic imbalance, chronic inflammation, and vascular dysfunction.Lipid-sensing G protein-coupled receptors (GPCRs) have emerged as important molecular mediators that translate nutrient cues into coordinated metabolic and inflammatory responses.While several lipid-responsive GPCRs have been implicated in metabolic regulation, their roles in inter-organ communication between adipose tissue and the vasculature remain incompletely understood.GPR84, originally characterized in immune cells, is increasingly recognized as a receptor expressed in metabolically active adipose depots.Emerging evidence suggests that GPR84 may contribute to the maintenance of adipose metabolic function and influence adipose-derived signals that affect vascular homeostasis.By integrating lipid sensing with adipose tissue biology, GPR84 may represent a regulatory node linking metabolic stress to atherosclerotic progression.Further clarification of its tissue-specific functions may provide new insights into the pathophysiology of cardiometabolic disease and identify potential therapeutic opportunities.
Förderung
- Korea Bio Research Association
Zitieren
APA
Han, C. Y., & Oh, D. Y. (2026). Lipid-sensing GPCRs in Cardiometabolic Diseases: Emerging Roles for GPR84. KOBRA Reports, 2. https://doi.org/10.64066/kobrareports.26.0015
Vancouver
Han CY, Oh DY. Lipid-sensing GPCRs in Cardiometabolic Diseases: Emerging Roles for GPR84. KOBRA Reports. 2026;2. doi:10.64066/kobrareports.26.0015
BibTeX
@article{Han2026,
author = {Han, Chang Yeob and Oh, Da Young},
title = {Lipid-sensing GPCRs in Cardiometabolic Diseases: Emerging Roles for GPR84},
journal = {KOBRA Reports},
year = {2026},
volume = {2},
doi = {10.64066/kobrareports.26.0015}
}
EUVIMED